Quest diagnostics introduces testing for oropouche virus

Diagnostic testing for emerging infectious disease associated with severe neurological affects secaucus, n.j. , july 15, 2025 /prnewswire/ -- quest diagnostics (nyse: dgx), a leader in diagnostic information services, today announced the launch of a new diagnostic laboratory test for the oropouche virus, an emerging disease that is increasingly found in south and central america and the caribbean.
DGX Ratings Summary
DGX Quant Ranking